[Review in geriatric medicine 2011].
In 2011, new tools to evaluate life expectancy are available. Controversy about PSA-based screening for prostate cancer is still going on, with new data from the US Preventive services task force. A brief behavioral treatment for insomnia can be efficient and durable. Gliptines are be useful to avoid treatment-induced hypoglycemia in diabetic patients. New Alzheimer diagnostic criteria, including biomarkers, have been published.
Service de gériatrie et de réadaptation gériatrique, Département de médecine, CHUV, 1011 Lausanne. stephane.rochat@chuv.ch
S
S
Rochat
N
N
Doser
S
S
Eyer
A
A
Jabri
E
E
Rubli
C
C
Büla
D000375:Aging; D000544:Alzheimer Disease / Q000175:diagnosis; D001521:Behavior Therapy; D014408:Biomarkers, Tumor / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D055088:Early Detection of Cancer; D005853:Geriatrics / Q000639:trends; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D008017:Life Expectancy; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis / Q000517:prevention & control; D011614:Psychotherapy, Brief; D016032:Randomized Controlled Trials as Topic; D007319:Sleep Initiation and Maintenance Disorders / Q000628:therapy
D014408:Biomarkers, Tumor; D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D017430:Prostate-Specific Antigen